# InvestSud

> InvestSud is a VC fund in Washington backing Medical and Biotechnology. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Washington, United States
- Total investments: 2
- Last investment: Nov 2024
- Lead investor: 0%
- Last updated: Aug 2026
- Website: https://investsud.com

InvestSud is a VC fund in Washington focused on Medical and Biotechnology. InvestSud provides its clients a complete package from offering investment opportunities to raising funds and provides legal counseling in all kinds of industries such as mining, energy, infrastructure, technology, pharmaceutical, real estate, agribusiness, and fishery, using its global network with international funds and law firms.

## Contacts

5 contacts available for InvestSud. Shizune tracks 1 team members at InvestSud. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/investsud-9c11?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Biotechnology | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Funding Round | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Juan Eyzaguirre Letelier | CEO & Founder | 0 | https://shizune.co/investors/profile/juan-eyzaguirre-letelier |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AdipoPharma | AdipoPharma SAS is dedicated to learning more about the role of adipocyte cells in diabetes. AdipoPharma is using the adipocyte's power to treat insulin resistance, type 2 diabetes, and other diseases. |  |  | Nov 11, 2024 |  |
| AdipoPharma | AdipoPharma SAS is dedicated to learning more about the role of adipocyte cells in diabetes. AdipoPharma is using the adipocyte's power to treat insulin resistance, type 2 diabetes, and other diseases. | $10.6M | Series A | Nov 11, 2024 |  |

2 of 2 investments shown.

## Co-investors
- [Good Growth Capital](https://shizune.co/investors/profile/good-growth-capital) — VC Fund, 2 deals together
- [Newton Biocapital](https://shizune.co/investors/profile/newton-biocapital) — VC Fund, 2 deals together
- [Okeanos](https://shizune.co/investors/profile/riverbend-capital) — VC Fund, 2 deals together
- [Sambrinvest](https://shizune.co/investors/profile/sambr-invest) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does InvestSud invest in?

InvestSud invests primarily in Medical, Biotechnology and Pharmaceutical startups, most often at Series A and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact InvestSud?

Public channels for InvestSud include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at InvestSud?

The team at InvestSud includes Juan Eyzaguirre Letelier (CEO & Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co